Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (331-340 of 354) with videos related to

Pageof 36
Sort By:
Blood|September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphomaGabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
The New England Journal of Medicine|November 27, 2014
Age-related clonal hematopoiesis associated with adverse outcomesSiddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Cell|August 1, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian W Windsor, et al.
Nature Biotechnology|August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantationNicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Blood|April 30, 2020
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDSLuca Malcovati, Kristen Stevenson, Elli Papaemmanuil, et al.
Cancer Cell|November 8, 2016
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic LeukemiaLili Wang, Angela N Brooks, Jean Fan, et al.
Blood|March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Yi Zhang, Alexandra Savell, et al.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Pageof 36

Showing results (331-340 of 354) with videos related to

Sort By:
Pageof 36
Blood|September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphomaGabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
The New England Journal of Medicine|November 27, 2014
Age-related clonal hematopoiesis associated with adverse outcomesSiddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Cell|August 1, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian W Windsor, et al.
Nature Biotechnology|August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantationNicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Blood|April 30, 2020
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDSLuca Malcovati, Kristen Stevenson, Elli Papaemmanuil, et al.
Cancer Cell|November 8, 2016
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic LeukemiaLili Wang, Angela N Brooks, Jean Fan, et al.
Blood|March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Yi Zhang, Alexandra Savell, et al.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Pageof 36